On February 19, the Catalan neurological community gathered for one of the most significant events of the year in the field of dementia: the Symposium “Anti-amyloid therapies in clinical practice: challenges and planning,” organized by the Cognition and Behavior Study Group of the Catalan Society of Neurology. The meeting was held in a hybrid format, with an in-person venue at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and online access open to healthcare professionals.
On February 19, the Catalan neurological community gathered for one of the most significant events of the year in the field of dementia: the Symposium “Anti-amyloid therapies in clinical practice: challenges and planning,” organized by the Cognition and Behavior Study Group of the Catalan Society of Neurology. The meeting was held in a hybrid format, with an in-person venue at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and online access open to healthcare professionals.
A space to analyze challenges and share experiences
The symposium was created to address a transformative moment in the field of Alzheimer’s disease. Anti-amyloid therapies, which have marked a turning point in international research, present new challenges that require coordinated planning and shared reflection among centers. For this reason, the event brought together professionals from various hospitals and institutions across Catalonia to analyze the current status of these interventions, share experiences, and explore organizational models that enable equitable and efficient implementation.
Throughout the afternoon, experts discussed key issues such as the logistical and healthcare challenges involved in incorporating these therapies, lessons learned from international experiences, and the specific needs of the Catalan healthcare system to ensure adequate and equitable access. The approach was both scientific and operational, with the aim of building a shared vision to help centers prepare for this new therapeutic paradigm.
The contribution of Ace Alzheimer Center Barcelona
Ace Alzheimer Center Barcelona played a prominent role in the event. a Dra. Pilar Sanz, pecific challenges faced by specialized dementia organizations. Her participation reinforced Ace’s commitment to innovation, institutional collaboration, and the continuous improvement of care for people with Alzheimer’s disease.
